Hem › Endometriecancer › Ohio › Cincinnati
Kliniska studier för Endometriecancer i Cincinnati, OH
13 studier för Endometriecancer söker deltagare vid platser i och runt Cincinnati (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekryterarFas 2
- Good Samaritan Hospital - Cincinnati, Cincinnati
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
RekryterarFas 2
- Research Site, Cincinnati
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
RekryterarFas 3
- University of Cincinnati Medical Center, Cincinnati
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RekryterarFas 3
- Research Site, Cincinnati
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekryterarFas 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekryterarFas 1
- St. Elizabeth Healthcare, Edgewood · 8 mi bort
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
RekryterarFas 2
- University of Cincinnati Cancer Center, Cincinnati
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- Oncology Hematology Care Primary, Cincinnati
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RekryterarFas 3
- Research Site, Cincinnati
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
RekryterarFas 3
- University of Cincinnati Physicians Group, LLC, Cincinnati
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
RekryterarFas 2
- University of Cincinnati Medical Center, Cincinnati
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
RekryterarFas 1/2
- The Christ Hospital, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Cincinnati
Endometriecancer-studier i andra städer
- Houston, TX68 studier
- New York City, NY52 studier
- Boston, MA50 studier
- Arlington, VA39 studier
- Nashville, TN38 studier
- Los Angeles, CA34 studier
- St. Louis, MO29 studier
- Philadelphia, PA28 studier
- San Antonio, TX27 studier
- Chicago, IL25 studier
- Columbus, OH25 studier
- Queens, NY25 studier
Andra studier i Cincinnati
- Icke-småcellig lungcancer35 studier
- Cancer (alla typer)27 studier
- Bröstcancer25 studier
- Hjärtsvikt24 studier
- Kolorektal cancer21 studier
- Akut myeloid leukemi20 studier
- Metastaserande cancer20 studier
- Äggstockscancer19 studier
- Lungcancer19 studier
- Övervikt19 studier
- Prostatacancer18 studier
- Multipelt myelom17 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.